326 related articles for article (PubMed ID: 1709847)
1. Involvement of brain catecholamines and acetylcholine in growth hormone deficiency states. Pathophysiological, diagnostic and therapeutic implications.
Müller EE; Locatelli V; Ghigo E; Cella SG; Loche S; Pintor C; Camanni F
Drugs; 1991 Feb; 41(2):161-77. PubMed ID: 1709847
[TBL] [Abstract][Full Text] [Related]
2. A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.
Ghigo E; Imperiale E; Boffano GM; Mazza E; Bellone J; Arvat E; Procopio M; Goffi S; Barreca A; Chiabotto P
J Endocrinol Invest; 1990 Apr; 13(4):307-16. PubMed ID: 2115060
[TBL] [Abstract][Full Text] [Related]
3. Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications.
Müller EE; Rolla M; Ghigo E; Belliti D; Arvat E; Andreoni A; Torsello A; Locatelli V; Camanni F
Drugs; 1995 Nov; 50(5):805-37. PubMed ID: 8586028
[TBL] [Abstract][Full Text] [Related]
4. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men.
Devesa J; Diaz MJ; Tresguerres JA; Arce V; Lima L
J Clin Endocrinol Metab; 1991 Aug; 73(2):251-6. PubMed ID: 1677361
[TBL] [Abstract][Full Text] [Related]
5. Regulation of hypothalamic somatostatin by glucocorticoids.
Devesa J; Barros MG; Gondar M; Tresguerres JA; Arce V
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):277-82. PubMed ID: 7626468
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic studies with intravenous and intranasal growth hormone-releasing peptide-2 in children of short stature.
Pihoker C; Middleton R; Reynolds GA; Bowers CY; Badger TM
J Clin Endocrinol Metab; 1995 Oct; 80(10):2987-92. PubMed ID: 7559885
[TBL] [Abstract][Full Text] [Related]
7. Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects.
Cordido F; Dieguez C; Casanueva FF
J Clin Endocrinol Metab; 1990 May; 70(5):1361-70. PubMed ID: 2159483
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoids may inhibit growth hormone release by enhancing beta-adrenergic responsiveness in hypothalamic somatostatin neurons.
Lima L; Arce V; Diaz MJ; Tresguerres JA; Devesa J
J Clin Endocrinol Metab; 1993 Feb; 76(2):439-44. PubMed ID: 8094392
[TBL] [Abstract][Full Text] [Related]
9. Comparison of growth hormone-releasing effect of growth hormone-releasing hormone, clonidine and pyridostigmine in normal children and adolescents. GH-releasing effect of GHRH, clonidine and pyridostigmine.
Ghigo E; Arvat E; Nicolosi M; Mazza E; Camanni F
Panminerva Med; 1990; 32(1):1-3. PubMed ID: 2263395
[TBL] [Abstract][Full Text] [Related]
10. Pyridostigmine potentiates L-dopa- but not arginine- and galanin-induced growth hormone secretion in children.
Ghigo E; Bellone J; Imperiale E; Arvat E; Mazza E; Valetto MR; Boffano GM; Cappa M; Loche S; De Sanctis C
Neuroendocrinology; 1990 Jul; 52(1):42-5. PubMed ID: 1697660
[TBL] [Abstract][Full Text] [Related]
11. Activation of cholinergic neurotransmission by pyridostigmine reverses the inhibitory effect of hyperglycemia on growth hormone (GH) releasing hormone-induced GH secretion in man: does acute hyperglycemia act through hypothalamic release of somatostatin?
Peñalva A; Burguera B; Casabiell X; Tresguerres JA; Dieguez C; Casanueva FF
Neuroendocrinology; 1989 May; 49(5):551-4. PubMed ID: 2566942
[TBL] [Abstract][Full Text] [Related]
12. Neurotransmitter control of growth hormone secretion in children after cranial radiation therapy.
Jorgensen EV; Schwartz ID; Hvizdala E; Barbosa J; Phuphanich S; Shulman DI; Root AW; Estrada J; Hu CS; Bercu BB
J Pediatr Endocrinol; 1993; 6(2):131-42. PubMed ID: 8102303
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of growth hormone (GH) deficiency in adults with hypothalamic-pituitary disorders: comparison of test results using pyridostigmine plus GH-releasing hormone (GHRH), clonidine plus GHRH, and insulin-induced hypoglycemia as GH secretagogues.
Hoeck HC; Vestergaard P; Jakobsen PE; Falhof J; Laurberg P
J Clin Endocrinol Metab; 2000 Apr; 85(4):1467-72. PubMed ID: 10770183
[TBL] [Abstract][Full Text] [Related]
14. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity.
Cordido F; Casanueva FF; Dieguez C
J Clin Endocrinol Metab; 1989 Feb; 68(2):290-3. PubMed ID: 2493023
[TBL] [Abstract][Full Text] [Related]
15. Aspects of the neuroendocrine control of somatotropic function in calorically restricted dogs and patients with eating disorders: studies with cholinergic drugs.
Müller EE; Rolla M
Psychiatry Res; 1996 Apr; 62(1):51-63. PubMed ID: 8739115
[TBL] [Abstract][Full Text] [Related]
16. Age-dependent decrease in the growth hormone response to growth hormone-releasing hormone in normally cycling women.
Coiro V; Volpi R; Capretti L; Caffarri G; Davoli C; Chiodera P
Fertil Steril; 1996 Aug; 66(2):230-4. PubMed ID: 8690107
[TBL] [Abstract][Full Text] [Related]
17. Hypothalamic mediation of reduced GH secretion in diabetic rats: evidence for reduced cholinergic inhibition of somatostatin release.
Ismail I; Lewis M; Peters JR; Scanlon MF
J Neuroendocrinol; 1995 Apr; 7(4):311-8. PubMed ID: 7647774
[TBL] [Abstract][Full Text] [Related]
18. Studies of growth hormone secretion in calorically restricted dogs: effect of cholinergic agonists and antagonists, glucose and thyrotropin-releasing hormone.
Arce VM; Cella SG; Locatelli V; Müller EE
Neuroendocrinology; 1991 May; 53(5):467-72. PubMed ID: 1908062
[TBL] [Abstract][Full Text] [Related]
19. Preservation of dopaminergic and alpha-adrenergic function in children with growth hormone neurosecretory dysfunction.
Bercu BB; Root AW; Shulman DI
J Clin Endocrinol Metab; 1986 Oct; 63(4):968-73. PubMed ID: 3018032
[TBL] [Abstract][Full Text] [Related]
20. Aspects of the neuroendocrine control of growth hormone secretion in ageing mammals.
Müller EE; Cella SG; De Gennaro Colonna V; Parenti M; Cocchi D; Locatelli V
J Reprod Fertil Suppl; 1993; 46():99-114. PubMed ID: 8100277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
